N. Khalil and R. O'connor, Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment, Can Med Assoc J, vol.171, pp.153-160, 2004.

M. Smith, M. Dalurzo, P. Panse, J. Parish, and K. Leslie, Usual interstitial pneumonia-pattern fibrosis in surgical lung biopsies. Clinical, radiological and histopathological clues to aetiology, J Clin Pathol, vol.66, p.10831, 2013.

J. A. Bjoraker, J. H. Ryu, M. K. Edwin, J. L. Myers, H. D. Tazelaar et al., Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, vol.157, pp.199-203, 1998.

T. E. King, M. I. Schwarz, K. Brown, J. A. Tooze, T. V. Colby et al., Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality, Am J Respir Crit Care Med, vol.164, pp.1025-1032, 2001.

G. Raghu, D. Weycker, J. Edelsberg, W. Z. Bradford, and G. Oster, Incidence and prevalence of idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, vol.174, pp.810-816, 2006.

E. B. Meltzer and P. W. Noble, Idiopathic pulmonary fibrosis, Orphanet J Rare Dis, vol.3, p.8, 2008.

G. Raghu, H. R. Collard, J. J. Egan, F. J. Martinez, J. Behr et al., An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management, Am J Respir Crit Care Med, vol.183, pp.788-824, 2011.

R. Rafii, M. M. Juarez, T. E. Albertson, and A. L. Chan, A review of current and novel therapies for idiopathic pulmonary fibrosis, J Thorac Dis, vol.5, pp.48-73, 2013.

L. K. Gong, X. H. Li, H. Wang, L. Zhang, F. P. Chen et al., Effect of feitai on bleomycin-induced pulmonary fibrosis in rats, J Ethnopharmacol, vol.96, pp.537-544, 2005.

C. Egger, C. Cannet, C. Gérard, E. Jarman, G. Jarai et al., Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology, PLoS One, vol.8, p.63432, 2013.

D. A. Lipson and E. Van-beek, Functional Lung Imaging, Lung Biology in Health and Disease, vol.200, 2005.

J. Biederer, M. Beer, W. Hirsch, J. Wild, M. Fabel et al., MRI of the lung (2/3). Why? when? how?, Insights Imag, vol.3, pp.355-371, 2012.

J. M. Wild, H. Marshall, M. Bock, L. R. Schad, P. M. Jakob et al., MRI of the lung (1/3): methods, Insights Imag, vol.3, pp.345-353, 2012.

M. Wielpütz and H. U. Kauczor, MRI of the lung: state of the art, Diagn Interv Radiol, vol.18, pp.344-353, 2012.

A. L. Babin, C. Cannet, C. Gerard, D. Wyss, C. P. Page et al., Noninvasive assessment of bleomycin-induced lung injury and the effects of short-term glucocorticosteroid treatment in rats using MRI, J Magn Reson Imaging, vol.33, pp.603-614, 2011.

A. L. Babin, C. Cannet, C. Gerard, P. Saint-mezard, C. P. Page et al., Bleomycin-induced lung injury in mice investigated by MRI: model assessment for target analysis, Magn Reson Med, vol.67, pp.499-509, 2012.

, MR IMAGING AND CHARACTERIZATION OF PULMONARY FIBROSIS Contrast Media Mol. Imaging, vol.11, pp.396-404, 2016.

©. Copyright, , 2016.

R. E. Jacob, B. G. Amidan, J. Soelberg, and K. R. Minard, In vivo MRI of altered proton signal intensity and T2 relaxation in a bleomycin model of pulmonary inflammation and fibrosis, J Magn Reson Imaging, vol.31, pp.1091-1099, 2010.

P. Caravan, Y. Yang, R. Zachariah, A. Schmitt, M. Mino-kenudson et al., Molecular magnetic resonance imaging of pulmonary fibrosis in mice, Am J Respir Cell Mol Biol, vol.49, pp.1120-1126, 2013.

G. Vande-velde, D. Langhe, E. Poelmans, J. Dresselaers, T. Lories et al., Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression, Invest Radiol, vol.49, pp.691-698, 2014.

H. Karmouty-quintana, C. Cannet, S. Zurbruegg, F. X. Blé, J. R. Fozard et al., Bleomycin-induced lung injury assessed noninvasively and in spontaneously breathing rats by proton MRI, J Magn Reson Imaging, vol.26, pp.941-949, 2007.

A. Bianchi, F. Lux, O. Tillement, and Y. Crémillieux, Contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-DOTA-based nanoparticles, Magn Reson Med, vol.70, pp.1419-1426, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00797079

G. H. Glover and J. M. Pauly, Projection reconstruction techniques for reduction of motion effects in MRI, Magn Reson Med, vol.28, pp.275-289, 1992.

M. Zurek, L. Boyer, P. Caramelle, J. Boczkowski, and Y. Cremillieux, Longitudinal and noninvasive assessment of emphysema evolution in a murine model using proton MRI, Magn Reson Med, vol.68, pp.898-904, 2012.

A. Bianchi, S. Dufort, F. Lux, A. Courtois, O. Tillement et al., Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI, Magn Reson Mater Phys Biol Med, vol.27, pp.303-316, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01279126

D. J. Schrier, R. G. Kunkel, and S. H. Phan, The role of strain variation in murine bleomycin-induced pulmonary fibrosis, Am Rev Respir Dis, vol.127, pp.63-66, 1983.

G. Izbicki, M. J. Segel, T. G. Christensen, M. W. Conner, and R. Breuer, Time course of bleomycin-induced lung fibrosis, Int J Exp Pathol, vol.83, pp.111-119, 2002.

N. I. Chaudhary, A. Schnapp, and J. E. Park, Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model, Am J Respir Crit Care Med, vol.173, pp.769-776, 2006.

D. Negrini, A. Passi, and A. Moriondo, The role of proteoglycans in pulmonary edema development, Intensive Care Med, vol.34, pp.610-618, 2008.

C. Egger, C. Cannet, C. Gerard, A. Dunbar, B. Tigani et al., Hyaluronidase modulates bleomycin-induced lung injury detected noninvasively in small rodents by radial proton MRI, J Magn Reson Imaging, 2014.

B. Driehuys, G. P. Cofer, J. Pollaro, J. B. Mackel, L. W. Hedlund et al., Imaging alveolar-capillary gas transfer using hyperpolarized 129 Xe MRI, Proc Natl Acad Sci, vol.103, pp.18278-18283, 2006.

B. B. Moore and C. M. Hogaboam, Murine models of pulmonary fibrosis, Am J Physiol Lung Cell Mol Physiol, vol.294, pp.152-160, 2008.

H. S. Choi, Y. Ashitate, J. H. Lee, S. H. Kim, A. Matsui et al., Rapid translocation of nanoparticles from the lung airspaces to the body, Nat Biotechnol, vol.28, pp.1300-1313, 2010.

D. Vooght, V. Vanoirbeek, J. A. Haenen, S. Verbeken, E. Nemery et al., Oropharyngeal aspiration: an alternative route for challenging in a mouse model of chemical-induced asthma, Toxicology, vol.259, pp.84-89, 2009.

F. Lux, A. Mignot, P. Mowat, C. Louis, S. Dufort et al., Ultrasmall rigid particles as multimodal probes for medical applications, Angew Chem Int Ed, vol.50, pp.12299-12303, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00673713

A. Bianchi, S. Dufort, F. Lux, P. Y. Fortin, N. Tassali et al., Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents, Proc Natl Acad Sci U S A, vol.111, pp.9247-9252, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01115890

M. A. Bernstein, K. F. King, and X. J. Zhou, Handbook of MRI Pulse Sequences, 2004.

C. J. Bergin, J. M. Pauly, and A. Macovski, Lung parenchyma: projection reconstruction MR imaging, Radiology, vol.179, pp.777-781, 1991.

C. J. Bergin, D. C. Noll, J. M. Pauly, G. H. Glover, and A. Macovski, MR imaging of lung parenchyma: a solution to susceptibility, Radiology, vol.183, pp.673-676, 1992.

M. Zurek, A. Bessaad, K. Cieslar, and Y. Crémillieux, Validation of simple and robust protocols for high-resolution lung proton MRI in mice, Magn Reson Med, vol.64, pp.401-407, 2010.

M. Lederlin and Y. Crémillieux, Three-dimensional assessment of lung tissue density using a clinical ultrashort echo time at 3 tesla: a feasibility study in healthy subjects, J Magn Reson Imaging, vol.40, pp.839-847, 2014.

K. N. Watt, J. Bishop, B. J. Nieman, R. M. Henkelman, and X. J. Chen, Oxygen-enhanced MR imaging of mice lungs, Magn Reson Med, vol.59, pp.1412-1421, 2008.